Product Information
GNP REDNESS RELIEF EYE DROPS is a generic product labeled by AmerisourceBergen, priced at $0.1036 per ML under NDC 46122060605. Its NADAC has been published 58 times since Aug 27, 2025.
Strength
.25; .012 g/100mL; g/100mL
Manufacturer
AmerisourceBergenNDC
46122060605
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
GLYCERIN; NAPHAZOLINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
8/27/2019
Pharmacological Classes
Price Statistics
The NADAC for GNP REDNESS RELIEF EYE DROPS has been published 58 times since Aug 27, 2025, and over the history we have for it it has declined 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1036 per ML |
|---|---|
| All-time high | $0.1098 (Sep 10, 2025) |
| All-time low | $0.0947 (Apr 22, 2026) |
| 52-week high | $0.1077 |
| 52-week low | $0.0947 |
| Median price | $0.1036 |
| Average price | $0.1025 |
| Largest weekly change | +3.9% (Jul 22, 2026) |
| Weeks tracked | 58 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the glycerin, naphazoline HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
glycerin, naphazoline HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP REDNESS RELIEF EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for GNP REDNESS RELIEF EYE DROPS, manufactured by AmerisourceBergen, is $0.1036 per ML (NDC 46122060605), effective Sep 30, 2026.
How has the price of GNP REDNESS RELIEF EYE DROPS changed over time?
Over the history we have for it, the NADAC for GNP REDNESS RELIEF EYE DROPS has declined 5.7%. It has been tracked across 58 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for GNP REDNESS RELIEF EYE DROPS?
Since Aug 27, 2025, the NADAC for GNP REDNESS RELIEF EYE DROPS has ranged from a low of $0.0947 (Apr 22, 2026) to a high of $0.1098 (Sep 10, 2025), with a median of $0.1036 per ML.
Are there cheaper alternatives to GNP REDNESS RELIEF EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of GNP REDNESS RELIEF EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP REDNESS RELIEF EYE DROPS?
GNP REDNESS RELIEF EYE DROPS (NDC 46122060605) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.